Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)

3.245 -0.035 (-1.07%)

Delayed Quote Updated: 3:34 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Relmada Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Relmada Therapeutics, Inc. (RLMD) Investigation

May 11, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Earnings Scheduled For May 11, 2023 ↗

May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...

Via Benzinga

Earnings Preview For Relmada Therapeutics ↗

May 10, 2023

Via Benzinga

Preview: Relmada Therapeutics's Earnings ↗

March 22, 2023

Via Benzinga

Relmada Shares Nosedive As Another Depression Trial Goes Up In Smoke ↗

December 08, 2022

Via Benzinga

RELMADA ALERT: Bragar Eagel & Squire, P.C. is Investigating Relmada Therapeutics, Inc. on Behalf of Relmada Stockholders and Encourages Investors to Contact the Firm

May 09, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

RLMD INVESTOR NEWS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Relmada Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – RLMD

May 01, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Relmada Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

April 27, 2023

From The Schall Law Firm

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Relmada Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

April 26, 2023

From The Schall Law Firm

Via Business Wire

Earnings Scheduled For March 23, 2023 ↗

March 23, 2023

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.

Via Benzinga

Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023 ↗

January 17, 2023

In the race to create faster-acting, safer antidepressants, Vistagen (NASDAQ: VTGN) is starting the year strong as it gets ready to launch a Phase 1 Trial of its novel pherine nasal spray for Major...

Via Benzinga

Looking Into Relmada Therapeutics's Recent Short Interest ↗

January 03, 2023

Relmada Therapeutics's (NASDAQ:RLMD) short percent of float has fallen 13.6% since its last report. The company recently reported that it has 1.72 million shares sold short, which is 5.78% of all...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 29, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 28, 2022

Via Benzinga

Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

December 13, 2022

The Dow Jones closed higher by over 500 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 12, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 09, 2022

Via Benzinga

Looking Into Relmada Therapeutics's Recent Short Interest ↗

December 09, 2022

Relmada Therapeutics's (NASDAQ:RLMD) short percent of float has fallen 8.99% since its last report. The company recently reported that it has 2.77 million shares sold short, which is 9.31% of all...

Via Benzinga

S&P 500 Rises 0.5%; Ciena Posts Upbeat Q4 Results ↗

December 08, 2022

U.S. stocks traded higher toward the end of trading, with the NASDAQ gaining around 100 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 08, 2022

Via Benzinga

Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

December 08, 2022

Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.

Via Benzinga

Nasdaq Gains 100 Points; Rent the Runway Shares Spike Higher ↗

December 08, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday.

Via Benzinga

Dow Rises 150 Points; US Jobless Claims Increase To 230,000 ↗

December 08, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Thursday.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 08, 2022

During Thursday's trading, 138 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 08, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 02, 2022

On Friday, 72 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

November 29, 2022

On Tuesday, 89 companies set new 52-week lows.

Via Benzinga

121 Stocks That Hit Their 52-Week Low ↗

October 14, 2022

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022 ↗

October 14, 2022

Upgrades

Via Benzinga

Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday ↗

October 14, 2022

Gainers Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.